z-logo
open-access-imgOpen Access
Hepatitis C virus core+1/ARF protein decreases hepcidin transcription through an AP1 binding site
Author(s) -
Ioly KottaLoizou,
Niki Vassilaki,
Georgios Pissas,
Athanassios Kakkanas,
Latifa Bakiri,
Ralf Bartenschlager,
Penelope Mavromara
Publication year - 2013
Publication title -
journal of general virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.55
H-Index - 167
eISSN - 1465-2099
pISSN - 0022-1317
DOI - 10.1099/vir.0.050328-0
Subject(s) - ap 1 transcription factor , hepcidin , biology , activator (genetics) , stat protein , transcription (linguistics) , enhancer , microbiology and biotechnology , promoter , transcription factor , hbx , virology , hepatitis c virus , gene expression , virus , gene , hepatitis b virus , stat3 , signal transduction , immunology , biochemistry , linguistics , philosophy , inflammation
Chronic viral hepatitis C is characterized by iron accumulation in the liver, and hepcidin regulates iron absorption. Hepatitis C virus (HCV) core+1/ARFP is a novel protein produced by a second functional ORF within the core gene. Here, using reporter assays and HCV bicistronic replicons, we show that, similarly to core, core+1/ARFP decreases hepcidin expression in hepatoma cells. The activator protein 1 (AP1) binding site of the human hepcidin promoter, shown here to be relevant to basal promoter activity and to the repression by core, is essential for the downregulation by core+1/ARFP while the previously described C/EBP (CCAAT/enhancer binding protein) and STAT (signal transducer and activator of transcription) sites are not. Consistently, expression of the AP1 components c-jun and c-fos obliterated the repressive effect of core and core+1/ARFP. In conclusion, we provide evidence that core+1/ARFP downregulates AP1-mediated transcription, providing new insights into the biological role of core+1/ARFP, as well as the transcriptional modulation of hepcidin, the main regulator of iron metabolism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here